524 related articles for article (PubMed ID: 24581491)
1. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
Mori M; Triboulet R; Mohseni M; Schlegelmilch K; Shrestha K; Camargo FD; Gregory RI
Cell; 2014 Feb; 156(5):893-906. PubMed ID: 24581491
[TBL] [Abstract][Full Text] [Related]
2. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.
Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X
J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.
Garibaldi F; Falcone E; Trisciuoglio D; Colombo T; Lisek K; Walerych D; Del Sal G; Paci P; Bossi G; Piaggio G; Gurtner A
Oncogene; 2016 Jul; 35(29):3760-70. PubMed ID: 26996669
[TBL] [Abstract][Full Text] [Related]
4. Transcription and processing: multilayer controls of RNA biogenesis by the Hippo pathway.
Yu FX; Guan KL
EMBO J; 2014 May; 33(9):942-4. PubMed ID: 24639555
[TBL] [Abstract][Full Text] [Related]
5. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer.
Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP
Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Kim NG; Koh E; Chen X; Gumbiner BM
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between Hippo signalling and miRNAs in tumour progression.
Li N; Xie C; Lu N
FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
[TBL] [Abstract][Full Text] [Related]
8. Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
Takaoka Y; Shimizu Y; Hasegawa H; Ouchi Y; Qiao S; Nagahara M; Ichihara M; Lee JD; Adachi K; Hamaguchi M; Iwamoto T
PLoS One; 2012; 7(8):e42137. PubMed ID: 22876303
[TBL] [Abstract][Full Text] [Related]
9. Hippo signaling promotes JNK-dependent cell migration.
Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
[TBL] [Abstract][Full Text] [Related]
10. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review).
Arora T; Kausar MA; Aboelnaga SM; Anwar S; Hussain MA; Sadaf S; Kaur S; Eisa AA; Shingatgeri VMM; Najm MZ; Aloliqi AA
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35699111
[TBL] [Abstract][Full Text] [Related]
11. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
[TBL] [Abstract][Full Text] [Related]
12. WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.
Tabatabaeian H; Lim SK; Chu T; Seah SH; Lim YP
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34117091
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
[TBL] [Abstract][Full Text] [Related]
15. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
16. Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression.
Crose LE; Galindo KA; Kephart JG; Chen C; Fitamant J; Bardeesy N; Bentley RC; Galindo RL; Chi JT; Linardic CM
J Clin Invest; 2014 Jan; 124(1):285-96. PubMed ID: 24334454
[TBL] [Abstract][Full Text] [Related]
17. The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness.
Wu KJ
Biomed J; 2020 Apr; 43(2):107-114. PubMed ID: 32513392
[TBL] [Abstract][Full Text] [Related]
18. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
Hikasa H; Sekido Y; Suzuki A
Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
[TBL] [Abstract][Full Text] [Related]
19. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
[TBL] [Abstract][Full Text] [Related]
20. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
